Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119782) titled 'Clinical Observation of Denosumab in the Treatment of Rheumatoid Arthritis Complicated with Osteoporosis' on March 3.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Yuebei People's Hospital
Condition:
Rheumatoid arthritis
Osteoporosis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-03
Target Sample Size: Denosumab/Alendronate Sodium Observation Group:140;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=305663
Published by HT Digital Content Services with permission from Health Daily Digest....